Skip to content

Nutriomics and Artificial Intelligence Nutrition Obesity Cohort

Nutriomics and Artificial Intelligence Nutrition Obesity Cohort

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007860
Enrollment
650
Registered
2022-10-28
Start date
2022-10-01
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Group/Cohort Lable: The obese group group/Cohort Description: Obese patients (BMI =25 kg/m2) with chronic diseases such as cardiovascular disease, hypertension, diabetes, and metabolic syndrome. More than 10% of the patients in the obese group will be patients with a BMI =30. Group/Cohort Lable: The control group group/Cohort Description: Adults with BMI 18.5~24.9 kg/m2.

Exclusion criteria

Exclusion criteria: Criteria for excluding normal groups 1. Severe non-cardiovascular disease with a life expectancy of 6 months or less 2. Pregnant women or pregnant women are suspected or nursing 3. Those who are continuously taking medications prescribed by doctors for chronic diseases other than hypertension and dyslipidemia; 4. Within 5 years of being diagnosed with a malignant tumor 5. Those who have difficulty using smartphones Criteria for excluding obesity groups 1. Serious non-cardiovascular disease with a life expectancy of 6 months or less 2. Pregnant women or pregnant women suspected or nursing 3. Patients within 3 months of organ transplantation 4. Patients currently being treated for acute rejection of transplantation 5. Patients treated for acute coronary syndrome (myocardial infarction, unstable angina) and within 6 months of discharge 6. Patients treated in hospital for acute cerebral infarction and within 6 months of discharge Type 1 diabetes 8. Steroid, a patient taking female hormones 9. Those who have difficulty using smartphones

Design outcomes

Primary

MeasureTime frame
Differences of nutriomics according to obesity phenotypes

Secondary

MeasureTime frame
A composite of all-cause mortality, cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, revascularization of coronary artery, and heart failure hospitalization.

Countries

Korea, Republic of

Contacts

Public ContactDamhee An

Yonsei University Health System, Severance Hospital

dnjsfud333@naver.com+82-2-2228-8225

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026